About our e-newsletters
- Free e-newsletters
- Mayo Clinic expertise
- We do not share your e-mail address
Housecall, our weekly general-interest e-newsletter, keeps you up to date on a wide variety of health topics with timely, reliable, practical information, recipes, blogs, questions and answers with Mayo Clinic experts and more. Our biweekly topic-specific e-newsletters also include blogs, questions and answers with Mayo Clinic experts, and other useful information that will help you manage your health.
Housecall Archives
Mayo Clinic Housecall
Stay up to date on the latest health information.
What you get
- Free weekly e-newsletter
- Mayo Clinic expertise
- Recipes, tools and other helpful information
- We do not share your e-mail address
Definition
By Mayo Clinic staffWith childhood asthma, the lungs and airways become easily inflamed when exposed to certain triggers, such as airborne pollen. In other cases, childhood asthma flares up with a cold or other respiratory infection. Childhood asthma can cause bothersome daily symptoms that interfere with play, sports, school and sleep. In some children, unmanaged asthma can cause dangerous asthma attacks.
Childhood asthma isn't a different disease than asthma in adults, but children do face unique challenges. Asthma in children is a leading cause of emergency department visits, hospitalizations and missed school days. Unfortunately, childhood asthma can't be cured and symptoms may continue into adulthood. But with the right treatment, you and your child can keep symptoms under control and prevent damage to growing lungs.
- Robinson PD, et al. Asthma in childhood. Pediatric Clinics of North America. 2009;56:191.
- Liu AH. Childhood Asthma. In: Kliegman RM, et al. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, Pa.: Saunders; 2007. http://www.mdconsult.com/das/book/body/10te0024376-12/727446153/1608/440.html#4-u1.0-B978-1-4160-2450-7..50145-6--cesec11_3422. Accessed July 18, 2010.
- Stewart LJ. Pediatric asthma. Primary Care Clinics in Office Practice. 2008;35:25.
- Expert panel report 3 (EPR-3): Guidelines for the diagnosis and management of asthma. Bethesda, Md.: National Institutes of Health. http://www.nhlbi.nih.gov/guidelines/asthma/06_sec3_comp3.pdf. Accessed July 13, 2010.
- Updated information on leukotriene inhibitors: Montelukast (marketed as Singulair), zafirlukast (marketed as Accolate), and zileuton (marketed as Zyflo and Zyflo CR). U.S. Food and Drug Administration. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm165489.htm. Accessed July 13, 2010.
- FDA drug safety communication: New safety requirements for long-acting inhaled asthma medications called long-acting beta-agonists (LABAs). U.S. Food and Drug Administration. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm200776.htm. Accessed March 8, 2010.
- Bukutu C, et al. Asthma: A review of complementary and alternative therapies. Pediatrics in Review. 2008;29:e44.
- Mark JD. Integrative medicine and asthma. Pediatric Clinics of North America. 2007;54:1007.
- Lands LC. Nutrition in pediatric lung disease. Paediatric Respiratory Reviews. 2007;8:305.
Find Mayo Clinic on